Profile | GDS4284 / 226416_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1295.88 | 78 |
GSM687648 | Patient 402 control | 935.38 | 73 |
GSM687653 | Patient 403 control | 1534.73 | 80 |
GSM687658 | Patient 404 control | 1147.64 | 76 |
GSM687663 | Patient 411 control | 1315.65 | 78 |
GSM687668 | Patient 422 control | 1237.57 | 77 |
GSM687673 | Patient 424 control | 1323.6 | 78 |
GSM687678 | Patient 425 control | 1325 | 78 |
GSM687683 | Patient 427 control | 986.563 | 73 |
GSM687688 | Patient 428 control | 1405.16 | 79 |
GSM687695 | Patient 441 control | 1153.06 | 77 |
GSM687699 | Patient 443 control | 1187.47 | 77 |
GSM687704 | Patient 444 control | 1074.14 | 75 |
GSM687707 | Patient 448 control | 1091.61 | 76 |
GSM687712 | Patient 449 control | 1076.93 | 75 |
GSM687719 | Patient 450 control | 958.37 | 73 |
GSM687724 | Patient 451 control | 1030.77 | 75 |
GSM687728 | Patient 452 control | 1060.43 | 75 |
GSM687646 | Patient 401 treated 24h | 1241.6 | 77 |
GSM687649 | Patient 402 treated 24h | 953.358 | 73 |
GSM687665 | Patient 411 treated 24h | 1605.68 | 81 |
GSM687651 | Patient 402 treated 4 weeks | 1123.39 | 75 |
GSM687667 | Patient 411 treated 4 weeks | 1464.52 | 79 |
GSM687670 | Patient 422 treated 24h | 1078.29 | 75 |
GSM687671 | Patient 422 treated 4 weeks | 1308.52 | 78 |
GSM687654 | Patient 403 treated 24h | 1462.2 | 80 |
GSM687675 | Patient 424 treated 24h | 1554.49 | 80 |
GSM687685 | Patient 427 treated 24h | 1010.99 | 74 |
GSM687656 | Patient 403 treated 4 weeks | 1673.62 | 81 |
GSM687677 | Patient 424 treated 4 weeks | 1360.35 | 78 |
GSM687687 | Patient 427 treated 4 weeks | 1073.34 | 75 |
GSM687692 | Patient 428 treated 4h | 1549.36 | 80 |
GSM687716 | Patient 449 treated 4h | 1331.94 | 78 |
GSM687722 | Patient 450 treated 4h | 807.355 | 70 |
GSM687680 | Patient 425 treated 24h | 1327.37 | 78 |
GSM687690 | Patient 428 treated 24h | 1472.3 | 80 |
GSM687700 | Patient 443 treated 24h | 1211.01 | 77 |
GSM687705 | Patient 444 treated 24h | 1268.17 | 78 |
GSM687714 | Patient 449 treated 24h | 1301.02 | 78 |
GSM687721 | Patient 450 treated 24h | 1085.17 | 75 |
GSM687682 | Patient 425 treated 4 weeks | 1235.58 | 77 |
GSM687694 | Patient 428 treated 4 weeks | 1530.68 | 80 |
GSM687702 | Patient 443 treated 4 weeks | 1130.19 | 75 |
GSM687718 | Patient 449 treated 4 weeks | 1388.06 | 79 |
GSM687723 | Patient 450 treated 4 weeks | 1122.39 | 76 |
GSM687661 | Patient 404 treated 4h | 1006.18 | 74 |
GSM687710 | Patient 448 treated 4h | 1077.24 | 76 |
GSM687726 | Patient 451 treated 4h | 1339.83 | 78 |
GSM687730 | Patient 452 treated 4h | 697 | 65 |
GSM687660 | Patient 404 treated 24h | 1298.17 | 80 |
GSM687697 | Patient 441 treated 24h | 1110.2 | 76 |
GSM687709 | Patient 448 treated 24h | 988.532 | 74 |
GSM687725 | Patient 451 treated 24h | 1212.34 | 77 |
GSM687729 | Patient 452 treated 24h | 1096.99 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 1141.53 | 76 |
GSM687731 | Patient 452 treated 4 weeks | 1102.84 | 75 |